Differences between coverage of yellow fever vaccine and the first dose of measles-containing vaccine: A desk review of global data sources

Add time:08/06/2019    Source:sciencedirect.com

IntroductionThe strategy to Eliminate Yellow Fever Epidemics (EYE) is a global initiative that includes all countries with risk of yellow fever (YF) virus transmission. Of these, 40 countries (27 in Africa and 13 in the Americas) are considered high-risk and targeted for interventions to increase coverage of YF vaccine. Even though the World Health Organization (WHO) recommends that YF vaccine be given concurrently with the first dose of measles-containing vaccine (MCV1) in YF-endemic settings, estimated coverage for MCV1 and YF vaccine have varied widely. The objective of this study was to review global data sources to assess discrepancies in YF vaccine and MCV1 coverage and identify plausible reasons for these discrepancies.

We also recommend Trading Suppliers and Manufacturers of Reactive yellow 27 (cas 12226-54-9). Pls Click Website Link as below: cas 12226-54-9 suppliers

Prev:Synthesis of polyaluminium chloride/papermaking sludge-based organic polymer composites for removal of disperse yellow and reactive blue by flocculation
Next:Residual biomass of chia seeds (Salvia hispanica) oil extraction as low cost and eco-friendly biosorbent for effective reactive yellow B2R textile dye removal: Characterization, kinetic, thermodynamic and isotherm studies)